HOPX and neoplasm: The divergent expression of HOPX in the TME across different tumor types might be due to several factors, including alterations of tumor cells and stromal cells driven by genetic and epigenetic mechanisms, as well as complex interactions of tumor cells with immune cells and fibroblasts.